Eli Lilly and Company’s monoclonal antibody combination therapy helped prevent symptomatic Covid-19 infection among nursing home residents and staff in a Phase 3 trial, the company announced on ...

Eli Lilly & Co. is ending a clinical trial of its antibody drug bamlanivimab in hospitalized COVID-19 patients after federal researchers concluded the therapy produced no marked improvement.

While vaccines may help slow the COVID-19 pandemic over the next months, drug company Eli Lilly announced Tuesday that its treatments can help save lives in the meantime. The company's drug ...

Eli Lilly announced Tuesday it was pausing a trial of an experimental drug similar to one President Donald Trump claimed cured him of COVID-19. Monday, Johnson & Johnson halted a large-scale trial ...

Wall Street’s major market averages seesawed back and forth on Friday and finished mixed as Federal Reserve Governor ...

Eli Lilly & Co. said it plans to begin commercial sales of its Covid-19 monoclonal antibody treatment to states, hospitals and other healthcare providers this month, as the federal government’s ...

Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of ...